Jump to navigation Jump to search
|Source||Humanized (from mouse)|
|Chemical and physical data|
|Molar mass||147.7 kg/mol g·mol−1|
|(what is this?)|
Samalizumab is a humanized monoclonal antibody designed for oncology indications.
Samalizumab was developed by Alexion Pharmaceuticals.
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|